NCT01391507 - Pilot Study of COR-1 in Heart Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions

Cardiomyopathy, Dilated

Interventions

DRUG

0.9 % sodium chloride

Monthly intravenous injection for 6 months

DRUG

COR-1

Monthly intravenous injection for 6 months

DRUG

Standard therapy for heart failure

All patients will continue to receive standard therapy for heart failure (ie, in accordance with guidelines) throughout the study.

Trial Locations (4)

München

Regensburg

Tübingen

Würzburg